Scientists have uncovered a copper-based cooperation between two common human pathogens—Candida albicans and Pseudomonas aeruginosa—that allows them to build unusually tough biofilms. The discovery, published in a new study, reveals that these microbes manage copper levels in their shared environment to reinforce their protective structures.
The finding challenges the long-held view that these two pathogens are purely competitive. Instead, they appear to have evolved a coordinated "copper economy" that strengthens their collective defenses. This partnership may explain why mixed-species biofilms are notoriously difficult to eradicate in clinical settings.
Copper, while toxic to many microbes at high concentrations, serves as a critical signaling and structural element in this mutualistic arrangement. By precisely regulating copper uptake and release, the fungi and bacteria create a microenvironment that promotes biofilm stability. The study's authors emphasized that disrupting this copper balance could offer a new therapeutic target.
If researchers can develop compounds that interfere with this metal-sharing process, it might weaken biofilm integrity and make infections more susceptible to existing drugs. Such an approach could be particularly impactful for patients with compromised immune systems or medical implants, where mixed biofilms are common.
Experts caution that translating this lab-based mechanism into clinical treatments remains a long-term goal. The complex interplay between these pathogens and their host environment will require further study before therapeutic strategies can be validated.